pharmaphorum May 11, 2021
Amanda Barrell

Joined up thinking is the key to converting AI-driven advances into real benefits for healthcare systems, say NHSX.

Healthcare systems the world over have been facing the same challenges for some time – and the pandemic has only served to compound them.

Aging populations, a growing number of people living with long-term conditions, and dwindling resources meant the NHS was already being asked to do more with less before COVID-19 hit.

Now, on top of pre-existing skills gaps and funding shortages, it faces record-breaking waiting lists, and a race to understand and cater for people with an erstwhile unknown disease.

NHSX believes artificial intelligence (AI) could hold at least part of the answer – but where are we right now,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Provider, Survey / Study, Technology, Trends
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Investigators Train AI Systems to Predict RA Outcomes
Confronting the Digital Dilemma in Healthcare’s Quest for Innovation
Google goes all in with AI as it merges research teams
Unlocking Targeted Cancer Care: Biomarkers as the Key to Personalized Treatments

Share This Article